Japanese leader asks Pfizer for additional vaccine supply
Japanese Prime Minister Yoshihide Suga has asked the U.S. drug maker Pfizer Inc. for additional supplies of the COVID-19 vaccine to speed up the inoculation drive that lags behind many other countries
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Japanese Prime Minister Yoshihide Suga asked the U.S. drug maker Pfizer Inc. for additional supplies of the COVID-19 vaccine to speed up the inoculation drive that lags behind many other countries.
Suga, after holding talks with President Joe Biden at the White House wrapped up his Washington visit on Saturday with a phone call to Pfizer CEO Albert Bourla.
Suga requested Burla for additional supplies of the vaccine that would cover all eligible recipients by September, as well as to ensure the stable and prompt delivery of the ongoing vaccine shipments, Japanese officials said Sunday. No details were released.
According to the officials, Burla told Suga that Pfizer planned to closely coordinate with the Japanese government to discuss the requests.
Japan, with its domestic vaccine development still in early stages, has to rely on imports and has signed agreements with Pfizer, AstraZeneca and Moderna. The Pfizer vaccine is the only one Japan has approved so far.
Japan’s government says it has secured 314 million doses, enough to cover its entire population by the end of this year. That includes 144 million doses from Pfizer.
Inoculations started in mid-February and have covered less than 1% of the population. The slow process is hampered by the shortage of vaccines amid export controls by the European Union.
A recent surge in cases led the government to issue an alert status for Tokyo and nine other urban prefectures. It has also fueled doubts about whether or how the July 23-Aug. 8 Tokyo Olympics can go ahead.
Japan added 4,532 cases on Saturday for a total of 525,218 since the pandemic began, with 9,584 deaths.